A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

A federal appeals court on Wednesday revived part of a lawsuit accusing the Federal Reserve Bank of New York of illegally ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

TUESDAY, July 1, 2025 (HealthDay News) — On Monday, the U.S. Supreme Court said it will not hear a case brought by a group ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...